• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-494 的异位表达通过调节 SIRT1 和 c-Myc 抑制了胰腺癌的增殖、侵袭和化疗耐药性。

Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc.

机构信息

Pancreatic Disease Institute, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei Province, Wuhan City, China.

Hepatobiliary and Pancreatic Surgery, Zhejiang Provincial People's Hospital, Hangzhou, China.

出版信息

Gene Ther. 2015 Sep;22(9):729-38. doi: 10.1038/gt.2015.39. Epub 2015 Apr 28.

DOI:10.1038/gt.2015.39
PMID:25965392
Abstract

Recent researches demonstrate that microRNAs (miRNAs) are deregulated in numerous cancers and involved in tumorigenesis, whereas their influences on pancreatic cancer (PC) still need further elucidation. The present research revealed that miR-494 was significantly decreased in PC cell lines and tissues. Functional study showed that overexpressed miR-494 could remarkably inhibit proliferation of PC cells both in vitro and in vivo, which was due to induction of apoptosis, G1-phase arrest and senescence. Moreover, upregulated miR-494 significantly prohibited invasion of PC cells. Meanwhile, both c-Myc and SIRT1 was identified as targets of miR-494 through dual luciferase assay and further confirmed by the reverse correlation between miR-494 and c-Myc/SIRT1 in PC samples. Furthermore, co-transfection with c-Myc-RNAi and SIRT1-RNAi synergistically reduced c-Myc and SIRT1 expression, and inhibited proliferation of PC, which simulated the effects of miR-494 overexpression. On the contrary, co-overexpression of c-Myc and SIRT1 effectively rescued inhibition of overexpressed miR-494 on PC cells. The clinical characteristics further revealed that low miR-494 correlated with larger tumor size, late tumor node metastasis stage, lymphatic invasion, distant metastasis and poor prognosis. In conclusion, the present study indicated that miR-494 might serve as predictor and inhibitor in PC by directy downregulating the loop of c-Myc and SIRT1.

摘要

最近的研究表明,微小 RNA(miRNAs)在许多癌症中失调,参与肿瘤发生,而它们对胰腺癌(PC)的影响仍需要进一步阐明。本研究表明,miR-494 在 PC 细胞系和组织中显著下调。功能研究表明,过表达 miR-494 可显著抑制 PC 细胞的体外和体内增殖,这是由于诱导细胞凋亡、G1 期阻滞和衰老。此外,上调 miR-494 可显著抑制 PC 细胞的侵袭。同时,通过双荧光素酶报告实验鉴定出 c-Myc 和 SIRT1 是 miR-494 的靶标,并通过 miR-494 与 PC 样本中 c-Myc/SIRT1 的反向相关性进一步证实。此外,c-Myc-RNAi 和 SIRT1-RNAi 的共转染协同降低了 c-Myc 和 SIRT1 的表达,并抑制了 PC 的增殖,模拟了 miR-494 过表达的作用。相反,c-Myc 和 SIRT1 的共过表达有效挽救了过表达 miR-494 对 PC 细胞的抑制作用。临床特征进一步表明,低 miR-494 与更大的肿瘤大小、晚期肿瘤淋巴结转移分期、淋巴浸润、远处转移和不良预后相关。总之,本研究表明,miR-494 可能通过直接下调 c-Myc 和 SIRT1 的环,作为 PC 的预测因子和抑制剂。

相似文献

1
Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc.miR-494 的异位表达通过调节 SIRT1 和 c-Myc 抑制了胰腺癌的增殖、侵袭和化疗耐药性。
Gene Ther. 2015 Sep;22(9):729-38. doi: 10.1038/gt.2015.39. Epub 2015 Apr 28.
2
Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling.miR-199b的下调通过激活SIRT1和抑制CREB/KISS1信号通路与结直肠癌的远处转移相关。
Oncotarget. 2016 Jun 7;7(23):35092-105. doi: 10.18632/oncotarget.9042.
3
Chronic pancreatitis and pancreatic cancer demonstrate active epithelial-mesenchymal transition profile, regulated by miR-217-SIRT1 pathway.慢性胰腺炎和胰腺癌表现出活跃的上皮间质转化特征,受 miR-217-SIRT1 通路调控。
Cancer Lett. 2014 Dec 28;355(2):184-91. doi: 10.1016/j.canlet.2014.08.007. Epub 2014 Aug 27.
4
MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.微小RNA-652通过靶向锌指E盒结合蛋白1抑制酸性微环境诱导的胰腺癌细胞上皮-间质转化。
Oncotarget. 2015 Nov 24;6(37):39661-75. doi: 10.18632/oncotarget.5350.
5
Identification of miR-601 as a novel regulator in the development of pancreatic cancer.鉴定miR-601为胰腺癌发展中的一种新型调节因子。
Biochem Biophys Res Commun. 2017 Jan 29;483(1):638-644. doi: 10.1016/j.bbrc.2016.12.090. Epub 2016 Dec 18.
6
SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells.SIRT1 RNAi 敲低诱导胰腺癌细胞凋亡和衰老,抑制侵袭并增强化疗敏感性。
Gene Ther. 2011 Sep;18(9):920-8. doi: 10.1038/gt.2011.81. Epub 2011 Jun 16.
7
MiR-130b is a prognostic marker and inhibits cell proliferation and invasion in pancreatic cancer through targeting STAT3.miR-130b 是一种预后标志物,通过靶向 STAT3 抑制胰腺癌中的细胞增殖和侵袭。
PLoS One. 2013 Sep 10;8(9):e73803. doi: 10.1371/journal.pone.0073803. eCollection 2013.
8
MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.微小RNA-451:上皮-间质转化抑制剂及肝细胞癌的预后生物标志物
Oncotarget. 2015 Jul 30;6(21):18613-30. doi: 10.18632/oncotarget.4317.
9
Hypoxia-induced lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923/KRAS pathway.缺氧诱导的长链非编码RNA-NUTF2P3-001通过解除对miR-3923/KRAS通路的抑制作用促进胰腺癌的肿瘤发生。
Oncotarget. 2016 Feb 2;7(5):6000-14. doi: 10.18632/oncotarget.6830.
10
A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis.一个包含 miR-22、Sp1 和 c-Myc 的调控环调节乳腺癌侵袭和转移中的 CD147 表达。
Cancer Res. 2014 Jul 15;74(14):3764-78. doi: 10.1158/0008-5472.CAN-13-3555. Epub 2014 Jun 6.

引用本文的文献

1
The role of LncRNA-MANCR induced by HIF-1α drive the malignant progression of pancreatic cancer by targeting miRNA-494/SIRT1 signaling axis under hypoxic conditions.在缺氧条件下,由缺氧诱导因子-1α(HIF-1α)诱导产生的长链非编码RNA-MANCR(LncRNA-MANCR)通过靶向微小RNA-494/沉默信息调节因子1(miRNA-494/SIRT1)信号轴驱动胰腺癌的恶性进展。
Cancer Gene Ther. 2025 Apr 7. doi: 10.1038/s41417-025-00900-0.
2
The roles of lncRNAs and miRNAs in pancreatic cancer: a focus on cancer development and progression and their roles as potential biomarkers.长链非编码RNA和微小RNA在胰腺癌中的作用:聚焦于癌症的发生发展及其作为潜在生物标志物的作用
Front Oncol. 2024 Mar 15;14:1355064. doi: 10.3389/fonc.2024.1355064. eCollection 2024.
3

本文引用的文献

1
Expression and prognostic value of c-Myc and Fas (CD95/APO1) in patients with pancreatic cancer.c-Myc和Fas(CD95/APO1)在胰腺癌患者中的表达及预后价值
Int J Clin Exp Pathol. 2014 Jan 15;7(2):742-50. eCollection 2014.
2
SIRT1 enhances matrix metalloproteinase-2 expression and tumor cell invasion in prostate cancer cells.SIRT1 增强前列腺癌细胞中基质金属蛋白酶-2 的表达和肿瘤细胞侵袭。
Prostate. 2013 Apr;73(5):522-30. doi: 10.1002/pros.22592. Epub 2012 Oct 4.
3
Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancreatic cancer.
JAK1 Is a Novel Target of Tumor- and Invasion-Suppressive microRNA 494-5p in Colorectal Cancer.
JAK1是结直肠癌中肿瘤及侵袭抑制性微小RNA 494-5p的新靶点。
Cancers (Basel). 2023 Dec 20;16(1):24. doi: 10.3390/cancers16010024.
4
Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer.微小 RNA 在胰腺癌中的功能和潜在治疗意义。
Int J Mol Sci. 2023 Dec 15;24(24):17523. doi: 10.3390/ijms242417523.
5
Role of microRNA-494 in tumor progression.微小RNA-494在肿瘤进展中的作用。
Am J Transl Res. 2023 Nov 15;15(11):6342-6361. eCollection 2023.
6
Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer.非编码RNA:胰腺癌耐药性的新兴调节因子
Front Cell Dev Biol. 2023 Jul 25;11:1226639. doi: 10.3389/fcell.2023.1226639. eCollection 2023.
7
MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products.MYC 癌基因:天然产物治疗癌症的可用药靶。
Aging Dis. 2024 Apr 1;15(2):640-697. doi: 10.14336/AD.2023.0520.
8
Metformin Induces Apoptosis in Human Pancreatic Cancer (PC) Cells Accompanied by Changes in the Levels of Histone Acetyltransferases (Particularly, p300/CBP-Associated Factor (PCAF) Protein Levels).二甲双胍诱导人胰腺癌细胞凋亡,同时组蛋白乙酰转移酶水平发生变化(特别是p300/CBP相关因子(PCAF)蛋白水平)。
Pharmaceuticals (Basel). 2023 Jan 12;16(1):115. doi: 10.3390/ph16010115.
9
A Tale of Two: When Neural Stem Cells Encounter Hypoxia.双雄对决:神经干细胞遭遇缺氧。
Cell Mol Neurobiol. 2023 Jul;43(5):1799-1816. doi: 10.1007/s10571-022-01293-6. Epub 2022 Oct 29.
10
MicroRNAs, Long Non-Coding RNAs, and Circular RNAs in the Redox Control of Cell Senescence.微小RNA、长链非编码RNA和环状RNA在细胞衰老的氧化还原调控中的作用
Antioxidants (Basel). 2022 Feb 28;11(3):480. doi: 10.3390/antiox11030480.
HIC1 启动子的高甲基化和 HIC1/SIRT1 的异常表达可能有助于胰腺癌的发生。
Ann Surg Oncol. 2013 Dec;20 Suppl 3:S301-11. doi: 10.1245/s10434-012-2364-9. Epub 2012 May 3.
4
c-MYC and SIRT1 locked in a vicious cycle.c-MYC与SIRT1陷入恶性循环。
Oncotarget. 2012 Feb;3(2):112-3. doi: 10.18632/oncotarget.440.
5
The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop.c-MYC 癌蛋白、NAMPT 酶、SIRT1 抑制剂 DBC1 和 SIRT1 脱乙酰酶形成正反馈回路。
Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):E187-96. doi: 10.1073/pnas.1105304109. Epub 2011 Dec 21.
6
Sirt1 deacetylates c-Myc and promotes c-Myc/Max association.Sirt1 去乙酰化 c-Myc 并促进 c-Myc/Max 复合物的形成。
Int J Biochem Cell Biol. 2011 Nov;43(11):1573-81. doi: 10.1016/j.biocel.2011.07.006. Epub 2011 Jul 22.
7
SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability.SIRT1 通过涉及 MKP3 和 ERK 对 N-Myc 蛋白稳定性影响的正反馈环促进 N-Myc 癌发生。
PLoS Genet. 2011 Jun;7(6):e1002135. doi: 10.1371/journal.pgen.1002135. Epub 2011 Jun 16.
8
SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells.SIRT1 RNAi 敲低诱导胰腺癌细胞凋亡和衰老,抑制侵袭并增强化疗敏感性。
Gene Ther. 2011 Sep;18(9):920-8. doi: 10.1038/gt.2011.81. Epub 2011 Jun 16.
9
MYC in oncogenesis and as a target for cancer therapies.MYC 在肿瘤发生中的作用及其作为癌症治疗靶点。
Adv Cancer Res. 2010;107:163-224. doi: 10.1016/S0065-230X(10)07006-5.
10
Overexpressed miR-494 down-regulates PTEN gene expression in cells transformed by anti-benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxide.过表达的 miR-494 下调抗苯并[a]芘-反-7,8-二氢二醇-9,10-环氧化物转化细胞中的 PTEN 基因表达。
Life Sci. 2010 Jan 30;86(5-6):192-8. doi: 10.1016/j.lfs.2009.12.002. Epub 2009 Dec 16.